Skip to main content
Assets
Thermo Fisher Scientific logo
TMO.NYSE
Thermo Fisher Scientific
Health Care · Life Sciences Tools & Services

Global specialist in serving science enabling customers to make the world healthier, cleaner, and safer through laboratory equipment and services.

HQ: United StatesListed: United States

Profile & Fundamentals

Thermo Fisher Scientific: Company identity, ownership, reported financial performance, balance sheets, and corporate actions.

Profile & Fundamentals

Thermo Fisher Scientific Profile & Fundamentals

Examine company identity, ownership, reported performance, valuation, balance-sheet resilience, dividends, buybacks, and material corporate events.

Interactive annual & quarterly chartsAI financial reviewsReported source tables
Explore this pageJump to a Profile & Fundamentals section

Company and Market Context

Company Profile & Ownership

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

TMO.NYSE

Company profile record

Thermo Fisher Scientific Inc

Common Stock · Health Care · Life Sciences Tools & Services

Official website

Company

Company / asset
Thermo Fisher Scientific Inc
Security type
Common Stock
Sector
Health Care
Industry
Life Sciences Tools & Services
HQ
🇺🇸 United States
Head office
168 Third Avenue, Waltham, MA, United States, 02451

Leadership & scale

Chief executive
Mr. Marc N. Casper
CEO year born
1968
Full-time employees
125K
Fiscal year end
December
IPO date
1978-01-13

Fundamentals snapshot

Updated 2026-09-13
Market Cap
USD 241.7B
P/E
34.6x
Revenue (Q2 26)
USD 12.0B
Profit (Q2 26)
USD 1.7B
Dividend Yield
0.2%
Revenue (FY 25)
USD 44.6B
Shares in public float
368.8M
Insider ownership
0.13%

Reporting & identifiers

Symbol
TMO.NYSE
Listing
🇺🇸 United States | Dividend Tax: 30%
Ticker Currency
USD
Income Statement Currency
USD
Balance Sheet Currency
USD
Cash Flow Currency
USD
EPS Currency
USD
Contract Type
SPOT
ISIN
US8835561023
Asset ID
equity_b5649eae-cacd-5a55-b622-d2acb17d1247

Ownership

Shares Outstanding

Shares OutstandingAnnual reported shares outstanding. Values in shares.362.9M375.45M388M400.55M413.1MJan 2017Apr 2019Jul 2021Oct 2023Jan 2026
  • Shares outstanding
Annual reported shares outstanding. Values in shares.

Top holders

  1. BlackRock Inc30,427,192 shares · 8.23% · Reported 2026-03-31
  2. Vanguard Capital Management, LLC24,280,816 shares · 6.57% · Reported 2026-03-31
  3. State Street Corp16,731,668 shares · 4.53% · Reported 2026-03-31
  4. CI Private Wealth LLC16,191,744 shares · 4.38% · Reported 2026-06-30
  5. Vanguard MStar Total Stk Mkt Idx Invest11,833,455 shares · 3.20% · Reported 2026-07-31
  6. Morgan Stanley - Brokerage Accounts10,863,528 shares · 2.94% · Reported 2026-03-31
  7. FMR Inc10,776,436 shares · 2.91% · Reported 2026-03-31
View more holders (8)
  1. Vanguard 500 Index Investor9,754,245 shares · 2.64% · Reported 2026-07-31
  2. Geode Capital Management, LLC8,407,891 shares · 2.27% · Reported 2026-03-31
  3. Franklin Templeton Inc6,813,031 shares · 1.84% · Reported 2026-03-31
  4. JPMorgan Chase & Co6,795,482 shares · 1.84% · Reported 2026-03-31
  5. T. Rowe Price Associates, Inc.6,315,471 shares · 1.71% · Reported 2026-03-31
  6. Capital World Investors6,195,370 shares · 1.68% · Reported 2026-06-30
  7. Vanguard Portfolio Management, LLC6,163,370 shares · 1.67% · Reported 2026-03-31
  8. Bank of America Corp5,533,403 shares · 1.50% · Reported 2026-03-31

Earnings, Profitability & Valuation

Earnings & Revenue

Revenue, Net Income, and Free Cash Flow

Revenue, Net Income, and Free Cash FlowAnnual reported financial results, converted using the statement's recorded USD conversion. Missing values are omitted. Values in USD.-2.27B10.6B23.47B36.34B49.2BDec 2016Apr 2019Jul 2021Oct 2023Dec 2025
  • Revenue
  • Free cash flow
  • Net income
Annual reported financial results, converted using the statement's recorded USD conversion. Missing values are omitted. Values in USD.

Valuation

Historical P/E Ratio

Historical P/E RatioPublished valuation snapshots. Trailing four-quarter earnings where available; annual earnings otherwise. Non-positive earnings are omitted. Values in times earnings.30.4531.6132.7633.9135.06Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
  • Published P/E
Published valuation snapshots. Trailing four-quarter earnings where available; annual earnings otherwise. Non-positive earnings are omitted. Values in times earnings.

Profitability & Margins

Profitability Margins

Profitability MarginsAnnual gross, operating, net income and free cash flow divided by revenue for matching reporting dates. Values in percent.6.6918.5230.3542.1954.02Dec 2016Apr 2019Jul 2021Oct 2023Dec 2025
  • Gross margin
  • Operating margin
  • Net margin
  • Free cash flow margin
Annual gross, operating, net income and free cash flow divided by revenue for matching reporting dates. Values in percent.

Complete Research Workspace

Unlock the complete Profile & Fundamentals

Sign in to verify your access, or upgrade to the Base plan to open the complete profile & fundamentals and available source data.